MeSH tree: C06.405.469.158.188
For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage, and hospitalization, according to a study published ...
Mar 5, 2025
0
10
According to the National Institutes of Health, between 600,000 and 900,000 Americans have ulcerative colitis, a chronic inflammatory disease of the large intestine.
Mar 5, 2025
0
38
Drinking two small glasses of cherry juice a day may reduce gut inflammation and boost quality of life in bowel disease patients, a new study shows. The work is published in the journal Life.
Mar 3, 2025
0
224
Specialists from the Digestive System Department at Hospital Germans Trias have conducted and published a unique study that represents a significant improvement in the monitoring and treatment of patients who have undergone ...
Feb 27, 2025
0
12
Scarring is expected after most operations, but surgical adhesions present a unique challenge for patients and surgeons. These internal bands of scar tissue can bind organs to each other or to the wall of the abdomen, causing ...
Feb 27, 2025
0
14
Widely used by the food industry, emulsifiers—a type of food additive—are found in many daily foods (sliced bread, ice creams, crème fraîche, plant milks, etc.). Given their omnipresence in our diet, the health effects of ...
Feb 11, 2025
0
21
A four year-long research study has found that particles secreted by an intestinal worm may assist in treating inflammatory bowel disease (IBD), an ailment suffered by millions of people globally.
Feb 6, 2025
0
44
Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a study published in the March issue of the International Journal of Cardiology Cardiovascular Risk and ...
Feb 5, 2025
0
18
An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions associated with the inflammation of the eye's iris, also known as anterior uveitis. The research also uncovered ...
Jan 30, 2025
0
30
The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults.
Jan 17, 2025
0
17
